# PET [89Zr]DFO-starPEG in Solid Tumors

> **NCT06894745** · PHASE1 · RECRUITING · sponsor: **Robert Flavell, MD, PhD** · enrollment: 13 (estimated)

## Conditions studied

- Solid Tumor
- Solid Carcinoma
- Soft Tissue Lesion

## Interventions

- **DRUG:** 89-zr-dfo-star polyethylene glycol (StarPEG)
- **PROCEDURE:** Whole Body Positron Emission Tomography (PET)
- **PROCEDURE:** Specimen Collection

## Key facts

- **NCT ID:** NCT06894745
- **Lead sponsor:** Robert Flavell, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2025-07-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894745, "PET [89Zr]DFO-starPEG in Solid Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06894745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*